Live feed
Filing
SC 13G
SC 13G0000921895-24-001868·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Tenax Therapeutics, Inc.
Security class unavailable · CUSIP: 88032L605
Event date: 2024-08-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-24-001868
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Aug 19, 2024
- Reporting period
- Aug 08, 2024
- Description
- Schedule 13G beneficial ownership